Table 1 Baseline characteristics of the patient population
Characteristics | RFA+MLT (n = 21) | Surgery (n = 21) | P value |
|---|---|---|---|
Age (years) | |||
Mean (SD) | 58.48 (10.96) | 58.47 (11.36) | 0.9977 |
Range (years) | 38–82 | 36–78 | — |
Gender (n, %) | 1 | ||
Men | 8 (38.10) | 8 (38.10) | |
Women | 13 (61.90) | 13 (61.90) | |
Smoking (n, %) | 3 (14.29) | 3 (14.29) | 1 |
Position (n, %) | |||
R.U.L. | 9 (42.86) | 7 (33.33) | 0.2389 |
R.M.L. | 1 (4.76) | 1 (4.76) | |
R.L.L. | 3 (14.29) | 5 (23.81) | |
L.U.L. | 6 (28.57) | 2 (9.52) | |
L.L.L. | 2 (9.52) | 6 (28.57) | |
Dominant tumor size (cm) | |||
Mean | 0.88 (0.22) | 0.89 (0.17) | 0.9028 |
Range (cm) | 0.7–1.3 | 0.7–1.2 | |
Dominant tumor feature (n, %) | 0.5178 | ||
pGGO | 13 (61.90) | 15 (71.43) | |
mGGO | 8 (38.10) | 6 (28.57) | |
Spicule sign (n, %) | 0.6825 | ||
With | 3 (14.29) | 4 (19.05) | |
None | 18 (85.71) | 17 (80.95) | |
Pathology (n, %) | 1 | ||
AAH | 10 (47.62) | 10 (47.62) | |
AIS | 11 (52.38) | 11 (52.38) | |
Lung function | |||
FEV1 (L) | 2.61 (0.85) | 2.39 (0.72) | 0.3709 |
FEV1 measured/anticipated % | 96.26 (16.36) | 88.14 (7.26) | 0.0441 |
VCMAX (L) | 3.16 (0.90) | 2.83 (0.61) | 0.1719 |
VCMAX measured/anticipated % | 93.95 (12.31) | 88.20 (8.58) | 0.0867 |
